Skip to main content
. 2019 Sep 3;9:12706. doi: 10.1038/s41598-019-48971-y

Figure 3.

Figure 3

CSC inhibits the phosphorylated CFTR activity in CR-HBE and following ligand-induced activation of CFBE. (a) Effect of CSC (200 μg/ml) or DMSO on forskolin activated Isc in CR-HBEWT/WT cells. (b) Summary CSC (200 μg/ml) or DMSO effect after 20 min on forskolin-stimulated CFTR-mediated Isc. Each dot represents the average of 2–4 technical replicates per cell-line from five individuals. *p < 0.05 (c) Representative Isc traces on CFBE after isoproterenol (Iso, delta concentration: 0.03, 0.1, 0.3, 1, and 10 μM), forskolin (0.01, 0.04, 0.1, 0.2, 1, 2, and 10 μM) or VIP (0.1, 0.3, 1.0, 3.0, 10, and 100 nM) stimulation. (d) Summary of maximal CFTR-mediated current stimulation by Isoproterenol (50 μM) and VIP (100 nM) compared to maximal forskolin stimulation (10 μM). Data are means ± SEM, n = 3 of technical duplicates *p < 0.05 (e) Representative Isc traces and summary figures (right panels, n = 3 with duplicates) of the β-adrenoreceptor agonist, isoproterenol activation (upper panels) or (f) VIP stimulation followed by CSC (200 μg/ml, black line) or DMSO administration.